Saturday 17 October 2026 Export DXR’s income statement to Excel — free account

Daxor Corporation

DXR Healthcare Medical Instruments & Supplies

Revenue growth for five consecutive years.

10.05 0.15 −1.47%

Follow DXR

Alert me

Market cap: $59.6M
P/E: 4.7×
Fwd P/E: 7.6×
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '21	Jun '22	Dec '22	Jun '23
ROE Full definition →	+7 more TTM periods Free account	17.94%	31.06%	44.47%	37.62%
ROA Full definition →		15.53%	25.53%	42.41%	35.90%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.40)	(1.49)	(1.55)	(1.68)
Free Cash Flow Full definition →		(5.65)	(6.02)	(6.29)	(7.52)
Other line items
Cash ROIC Full definition →		(22.70%)	(26.86%)	(20.84%)	(24.77%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		(1.86)	(1.26)	(0.63)	(0.89)
Revenue per Share Full definition →		(1.34)	(1.02)	(0.73)	(0.75)
Operating CF per Share Full definition →		(1.40)	(1.49)	(1.55)	(1.68)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates